Concepedia

Fatima Chowdhry

FC

Statistics

Publications

10

Citations

341

H-Index

10

Active since

2014

Affiliations

Eunice Kennedy Shriver National Institute of Child Health and Human Development(Current)

National Institutes of Health

National Institute of Mental Health

Supernus Pharmaceuticals (United States)

Virginia Commonwealth University

Fatima Chowdhry is an author at Eunice Kennedy Shriver National Institute of Child Health and Human Development specializing in social sciences, cognitive science, and brain function.

Top concepts

Publications per year

2014–2021

10

Publications

10

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Azmi Nasser, Tesfaye Liranso, Toyin Adewole et al. · Clinical Therapeutics · 2020 · 81 citations · Full text

Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial

Azmi Nasser, Tesfaye Liranso, Toyin Adewole et al. · Clinical Therapeutics · 2021 · 53 citations

, , +11

A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder

Azmi Nasser, Tesfaye Liranso, Toyin Adewole et al. · Journal of Clinical Psychopharmacology · 2021 · 40 citations · Full text

A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended-Release) in Adolescents with ADHD.

Azmi Nasser, Tesfaye Liranso, Toyin Adewole et al. · PubMed · 2021 · 36 citations · Full text

A machine learning approach to identify functional biomarkers in human prefrontal cortex for individuals with traumatic brain injury using functional near‐infrared spectroscopy

Nader Karamzadeh, Franck Amyot, Kimbra Kenney et al. · Brain and Behavior · 2016 · 33 citations · Full text

1–5 of 10